Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Brazil's data protection watchdog ANDP has banned Tools for Humanity from offering payment for iris scanning in the country.
Donald Trump has announced the 500 billion US dollar AI data center. However, only OpenAI is set to benefit from this.
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.